The
report " Bradykinin B1 Receptor (B1R) - Pipeline Review, H1
2016 ", has been prepared based on an in-depth market analysis
with inputs from industry experts.
Global
Markets Directs, Bradykinin
B1 Receptor (B1R) - Pipeline Review, H1 2016,
provides in depth analysis on Bradykinin B1 Receptor (B1R) targeted
pipeline therapeutics.
The
report provides comprehensive information on the Bradykinin B1
Receptor (B1R) , targeted therapeutics, complete with analysis by
indications, stage of development, mechanism of action (MoA), route
of administration (RoA) and molecule type. The report also covers the
descriptive pharmacological action of the therapeutics, its complete
research and development history and latest news and press releases.
Additionally, the report provides an overview of key players involved
in Bradykinin B1 Receptor (B1R) targeted therapeutics development and
features dormant and discontinued projects.
Global
Markets Directs report features investigational drugs from across
globe covering over 20 therapy areas and nearly 3,000 indications.
The report is built using data and information sourced from Global
Markets Directs proprietary databases, company/university websites,
clinical trial registries, conferences, SEC filings, investor
presentations and featured press releases from company/university
sites and industry-specific third party sources. Drug profiles
featured in the report undergoes periodic review following a
stringent set of processes to ensure that all the profiles are
updated with the latest set of information. Additionally, various
dynamic tracking processes ensure that the most recent developments
are captured on a real time basis.
The
report helps in identifying and tracking emerging players in the
market and their portfolios, enhances decision making capabilities
and helps to create effective counter strategies to gain competitive
advantage.
Download
Sample copy of this Report @
Scope
-
The report provides a snapshot of the global therapeutic landscape
for Bradykinin B1 Receptor (B1R)
-
The report reviews Bradykinin B1 Receptor (B1R) targeted therapeutics
under development by companies and universities/research institutes
based on information derived from company and industry-specific
sources
-
The report covers pipeline products based on various stages of
development ranging from pre-registration till discovery and
undisclosed stages
-
The report features descriptive drug profiles for the pipeline
products which includes, product description, descriptive MoA, R&D
brief, licensing and collaboration details & other developmental
activities
-
The report reviews key players involved in Bradykinin B1 Receptor
(B1R) targeted therapeutics and enlists all their major and minor
projects
-
The report assesses Bradykinin B1 Receptor (B1R) targeted
therapeutics based on mechanism of action (MoA), route of
administration (RoA) and molecule type
-
The report summarizes all the dormant and discontinued pipeline
projects
-
The report reviews latest news and deals related to Bradykinin B1
Receptor (B1R) targeted therapeutics
Reasons
to buy
-
Gain strategically significant competitor information, analysis, and
insights to formulate effective R&D strategies
-
Identify emerging players with potentially strong product portfolio
and create effective counter-strategies to gain competitive advantage
-
Identify and understand the targeted therapy areas and indications
for Bradykinin B1 Receptor (B1R)
-
Identify the use of drugs for target identification and drug
repurposing
-
Identify potential new clients or partners in the target demographic
-
Develop strategic initiatives by understanding the focus areas of
leading companies
-
Plan mergers and acquisitions effectively by identifying key players
and its most promising pipeline therapeutics
-
Devise corrective measures for pipeline projects by understanding
Bradykinin B1 Receptor (B1R) development landscape
-
Develop and design in-licensing and out-licensing strategies by
identifying prospective partners with the most attractive projects to
enhance and expand business potential and scope
Browse All reports Of this
Category: www.marketresearchreports.biz/category/109
Table
of Content :
Table
of Contents 2
List
of Tables 4
List
of Figures 4
Introduction
5
Global
Markets Direct Report Coverage 5
Bradykinin
B1 Receptor (B1R) Overview 6
Therapeutics
Development 7
Bradykinin
B1 Receptor (B1R) - Products under Development by Stage of
Development 7
Bradykinin
B1 Receptor (B1R) - Products under Development by Therapy Area 8
Bradykinin
B1 Receptor (B1R) - Products under Development by Indication 9
Bradykinin
B1 Receptor (B1R) - Pipeline Products Glance 10
Early
Stage Products 10
Bradykinin
B1 Receptor (B1R) - Products under Development by Companies 11
Bradykinin
B1 Receptor (B1R) - Products under Development by
Universities/Institutes 13
Bradykinin
B1 Receptor (B1R) - Therapeutics Assessment 15
Assessment
by Monotherapy/Combination Products 15
Assessment
by Mechanism of Action 16
Assessment
by Route of Administration 17
Assessment
by Molecule Type 18
Bradykinin
B1 Receptor (B1R) - Companies Involved in Therapeutics Development 20
Axxam
SpA 20
Boehringer
Ingelheim GmbH 21
Dompe
Farmaceutici S.p.A. 22
Grunenthal
GmbH 23
Bradykinin
B1 Receptor (B1R) - Drug Profiles 24
BI-113823
- Drug Profile 24
Product
Description 24
Mechanism
Of Action 24
R&D
Progress 24
Drug
to Antagonize Bradykinin Receptor B1 for Lupus Nephritis - Drug
Profile 25
Product
Description 25
Mechanism
Of Action 25
R&D
Progress 25
Small
Molecule to Antagonize Bradykinin B1 Receptor for Chronic
Inflammation - Drug Profile 26
Product
Description 26
Mechanism
Of Action 26
R&D
Progress 26
Small
Molecules to Antagonize BDKRB1 for Pain and Ophthalmic Disorders -
Drug Profile 27
Product
Description 27
Mechanism
Of Action 27
R&D
Progress 27
About
us
MarketResearchReports.biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Contact
us:
Mr.
Nachiket
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-618-1030
USA:
Canada Toll Free: 866-997-4948
No comments:
Post a Comment